about
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Septic arthritis by Sphingobacterium multivorum in imunocompromised pediatric patientAntibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Legionellosis must be kept in mind in case of pneumonia with lung abscesses in children receiving therapeutic steroids.Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015.Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.A guideline for the inpatient care of children with pyelonephritisSystemic use of fluoroquinolone in children.Current ciprofloxacin usage in children hospitalized in a referral hospital in ParisComparative analysis of quinolone resistance in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Chinese children and adults.Ciprofloxacin safety in paediatrics: a systematic review.Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulationHow do Midwives and Physicians Discuss Childhood Vaccination with Parents?Clinical characteristics of lung abscess in children: 15-year experience at two university hospitalsA comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis.Off-label drug use evaluation in paediatrics--applied to ciprofloxacin when used as treatment of cholangitis.Antibiotic prophylaxis in children with cancer or who have undergone hematopoietic cell transplantation.Fluoroquinolones in children: update of the literature.Safety Concerns Surrounding Quinolone Use in Children.Two fluoroquinolones and their combinations with hyaluronan: comparison of effects on canine chondrocyte culture.Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy.The quest for the best metric of antibiotic use and its correlation with the emergence of fluoroquinolone resistance in children.Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children.Moxifloxacin for the treatment of pulmonary tuberculosis in children: a single center experience.Brain abscess and epidural empyema caused by Salmonella enteritidis in a child: successful treatment with ciprofloxacin: a case report.Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.Oxidative stress-mediated myocardiotoxicity of ciprofloxacin and ofloxacin in juvenile rats.Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China.Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16.Ciprofloxacin Use in Hospitalized Children: Approved or Off-label?Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study.
P2860
Q24236124-8F4D3C26-D61A-4773-8DDF-33C83D9F8890Q24241438-FB2DA7F9-7F42-439E-8DB5-0E2273086B20Q28818779-52C5B3EC-F7AB-47EE-B536-BF42E77407C0Q31096335-845F2F30-0A9B-40ED-8C0B-360746B19927Q33268601-9D983A92-44A8-45DB-953E-4824AD58D57AQ33314977-D0B3D3A2-389E-432F-A7E1-3828314E919EQ33395991-760A02E7-A264-48CB-A4E4-31E54F785BE2Q33559453-F7C4E4BD-462B-482D-BD55-36F292CF8632Q33698908-232E47CC-1859-4D30-BF32-8E2FA5EEA12AQ34058260-14C20C66-4CF6-499F-A97C-B1421362F0C2Q34136077-4CB82D7F-86DC-4140-897A-D4175F53AD19Q34349032-0EA663C5-273C-4BD8-B3C0-8B6B6110B811Q34741643-B4323E43-7EE7-44D2-8D79-264D91E1B588Q35113712-C95C585D-5BD0-4229-A1CC-1ABCC5A813BAQ35161454-1DF6D5E4-BB64-4E2D-AF25-655502624CF4Q35210471-9DCCF121-D2BA-4D3C-BF46-FDA732AA2266Q35750465-6F4D7107-4955-4524-9757-EAB0FAE7F439Q36442150-29E0B194-81F2-4E06-974F-DC53A17915BFQ37506861-98AFD32D-007B-4C26-806F-997242765674Q37833575-13DA7442-4497-42D7-9D8E-C8FC551E7474Q38124015-E181CAAE-62D2-4BE7-B032-208609823342Q38534340-1729B3C1-E62D-4283-B03F-FCB69D25328FQ38728987-92628AF8-DD96-4708-AFF3-15ABE59466BAQ40758206-A1535EF9-0871-4391-8251-03A498DD2311Q41267412-FB088B11-EF42-4998-B166-219C84B813A5Q42215190-7CD5DE86-EBC0-488C-A38E-E5B47FD62F9FQ42220440-8B11F99D-FCD7-444B-8019-66F0E1C47A37Q42275450-8B09EB59-871A-4182-96A5-FDEDFB0301D6Q42549742-E34A7B52-A58C-46A7-AC7A-17BBB3CA4F91Q42591462-7EC92CA8-44DC-485A-86AB-392A5B3F28DEQ45963426-2B7D3F60-EB56-41B4-ABC5-F17D0188F8EBQ46264520-7BA83048-BDEA-4F71-9A4D-463E76A4D0ABQ47258596-17116E2D-14EF-4360-87EC-7A03C7EAB10EQ49237658-F57F25D2-741E-4866-9CB9-27C5A1854CC8Q54268209-1BC5E1B8-6B7D-4E4C-9438-D9C12BB13F30
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The use of systemic fluoroquinolones
@ast
The use of systemic fluoroquinolones
@en
The use of systemic fluoroquinolones
@nl
type
label
The use of systemic fluoroquinolones
@ast
The use of systemic fluoroquinolones
@en
The use of systemic fluoroquinolones
@nl
prefLabel
The use of systemic fluoroquinolones
@ast
The use of systemic fluoroquinolones
@en
The use of systemic fluoroquinolones
@nl
P3181
P356
P1433
P1476
The use of systemic fluoroquinolones
@en
P304
P3181
P356
10.1542/PEDS.2006-1722
P407
P577
2006-09-01T00:00:00Z